The batch was distributed between August 14, 2018 and September 5, 2018. One nonfatal adverse event has been reported during the timeframe the affected product was distributed. Ferring has announced a ...

ROCKVILLE, Md., Dec.4, 2007-- FDA notified healthcare professionals and patients of the Agency's request that manufacturers update the prescribing information for desmopressin to include important new ...

PARSIPPANY, N.J., Oct. 22, 2014 /PRNewswire-USNewswire/ – Ferring Pharmaceuticals is pleased to announce that the company has acquired DDAVP® (desmopressin acetate) from Sanofi. Ferring is the ...

Ferring Inc. is recalling three lots of DDAVP Spray (desmopressin acetate nasal solution, 10 micrograms/spray) because the product may contain a higher than labelled dose of the active ingredient ...

Dr. Reddy’s is launching desmopressin acetate injection, in a dosage strength of 4 mcg/mL. The product is the generic of Ferring’s DDAVP (desmopressin acetate) injection. “The launch of Desmopressin ...

Is Desmopressin acetate (DDAVP) for bed wetting the same as the The vasopressin analog desmopressin (DDAVP) known to enhance memory. Answer::Dear einstein, The Desmopressin is probably the same but as ...

Desmopressin acetate 4mcg/mL; soln for inj or IV infusion after dilution. DDAVP Injection is available as a sterile solution supplied as 4 mcg/mL in cartons of ten 1 mL single-dose, type 1 glass ...

Three forms of nasal spray are being recalled because they could contain too much of a man-made hormone used in treating conditions including a type of diabetes and frequent urination. Ferring ...

Feb. 18, 2005 — The U.S. Food and Drug Administration (FDA) has approved a first-time generic formulation of terconazole vaginal cream 0.4% for the treatment of vulvovaginal candidiasis; a first-time ...

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...

(RTTNews) - Dr. Reddy's Laboratories Ltd. (RDY) announced Wednesday the launch of Desmopressin Acetate Injection USP, 4 mcg/mL Single-dose Ampules in the U.S. market. Desmopressin Acetate Injection is ...